Status:
NOT_YET_RECRUITING
Urinary G3BP as a Novel Biomarker in Lupus Nephritis
Lead Sponsor:
Assiut University
Conditions:
Lupus Nephritis
Eligibility:
All Genders
18+ years
Brief Summary
Estimation of urinary Galectin-3 binding protein (u-Gal-3BP) in patients with systemic lupus erythematosus with and without lupus nephritis and in glomerulonephritis for other kidney diseases, Find th...
Detailed Description
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with multisystem involvement. The condition has several phenotypes, with varying clinical presentations from mild mucocutaneous mani...
Eligibility Criteria
Inclusion
- Any age above 18 years.
- Patient with Lupus nephritis diagnosed by biopsy.
- Patient with SLE without nephritis.
- Patient with nephritis of other reasons; acute proliferative glomerulonephritis (postinfectious and infection associated), crescentic glomerulonephritis, else.
Exclusion
- Pregnant.
- Patient who refused to be part of the study.
- Patients with estimated Glomerular Filtration Rate less than 15ml/min
Key Trial Info
Start Date :
September 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06520670
Start Date
September 1 2024
End Date
October 1 2025
Last Update
July 26 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.